Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 9,250 LYEL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 9,250 | n/a |
| May 19, 2025 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 130,000 | n/a |
| Jun 17, 2024 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 130,000 | n/a |
| May 23, 2024 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 36,490 | n/a |
| Apr 8, 2024 | NGM BIOPHARMACEUTICALS INC (NGM) | Tender of Shares | 5,172 | n/a |
| Apr 1, 2024 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 11,871 | $90.0K |
| Sep 8, 2023 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 55,000 | n/a |
| Jun 20, 2023 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 65,000 | n/a |
| May 25, 2023 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 12,940 | n/a |
| Apr 11, 2023 | RAPT Therapeutics, Inc. (RAPT) | Grant/Award | 6,026 | $87.5K |